PTCT - PTC Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.01B
Enterprise Value 31.71B
Trailing P/E N/A
Forward P/E 1-78.24
PEG Ratio (5 yr expected) 13.51
Price/Sales (ttm)8.20
Price/Book (mrq)6.97
Enterprise Value/Revenue 36.98
Enterprise Value/EBITDA 6-88.62

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin -25.03%
Operating Margin (ttm)-19.52%

Management Effectiveness

Return on Assets (ttm)-6.67%
Return on Equity (ttm)-28.02%

Income Statement

Revenue (ttm)244.69M
Revenue Per Share (ttm)5.58
Quarterly Revenue Growth (yoy)43.30%
Gross Profit (ttm)72.36M
EBITDA -19.28M
Net Income Avi to Common (ttm)-61.25M
Diluted EPS (ttm)-1.40
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)296.11M
Total Cash Per Share (mrq)6.34
Total Debt (mrq)148.87M
Total Debt/Equity (mrq)55.67
Current Ratio (mrq)4.34
Book Value Per Share (mrq)5.73

Cash Flow Statement

Operating Cash Flow (ttm)-10.36M
Levered Free Cash Flow (ttm)4.81M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.22
52-Week Change 3122.41%
S&P500 52-Week Change 38.07%
52 Week High 352.95
52 Week Low 314.87
50-Day Moving Average 343.77
200-Day Moving Average 336.70

Share Statistics

Avg Vol (3 month) 3940.53k
Avg Vol (10 day) 3626.2k
Shares Outstanding 550.27M
Float 41.46M
% Held by Insiders 13.57%
% Held by Institutions 192.71%
Shares Short (Sep 28, 2018) 43.72M
Short Ratio (Sep 28, 2018) 43.78
Short % of Float (Sep 28, 2018) 49.55%
Short % of Shares Outstanding (Sep 28, 2018) 47.40%
Shares Short (prior month Aug 31, 2018) 43.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A